Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial
Titel:
Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial
Auteur:
Roncero-Ramos, Irene Gutierrez-Mariscal, Francisco M. Gomez-Delgado, Francisco Villasanta-Gonzalez, Alejandro Torres-Peña, Jose D. Cruz-Ares, Silvia De La Rangel-Zuñiga, Oriol A. Luque, Raul M. Ordovas, Jose M. Delgado-Lista, Javier Perez-Martinez, Pablo Camargo, Antonio Alcalá-Diaz, Juan F. Lopez-Miranda, Jose